Register
Login:
Share:
Email Facebook Twitter


Tech company Mporium delivers an outstanding set of Q1 results says CEO De Groot
IronRidge Resources CEO hails spectacular lithium project and money making potential for gold




Share Price Information for Summit Ther (SUMM)


Share Price: 31.00Bid: 30.00Ask: 32.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 2.00Spread as %: 6.67%Open: 31.00High: 31.00Low: 30.00Yesterday’s Close: 31.00

Summit Therapeutics Plc Ord 1P

Summit Ther is listed in the FTSE AIM All-Share
Summit Ther is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
31.00
Share Price SpacerBid
30.00
Share Price SpacerAsk
32.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
88,703
Share Price SpacerOpen
31.00
Share Price SpacerHigh
31.00
Share Price SpacerLow
30.00
Share Price SpacerClose
31.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 160.39m £49.72m 3,000

52 Week High 202.50 52 Week High Date 22-MAY-2018
52 Week Low 17.00 52 Week Low Date 14-DEC-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
6 50,000 38,703 3.444 9.00 0.00 0.00


London South East Users info for Summit Ther




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-Apr-19
10:20:25
31.78
1,000
Buy* 
30.00
32.00
317.80
Trade Type:
Ordinary

23-Apr-19
09:07:50
30.51
50,000
Sell* 
30.00
32.00
15.26k
Trade Type:
Ordinary

23-Apr-19
08:27:31
31.84
1,000
Buy* 
30.00
32.00
318.40
Trade Type:
Ordinary




View more Summit Ther trades >>

Directors Deals for Summit Ther (SUMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
24-Oct-18Transfer From
Trade Notifier Information for Summit Therapeutics
Leopoldo Zambeletti held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Leopoldo Zambeletti
019,44415979
24-Oct-18Transfer From
Trade Notifier Information for Summit Therapeutics
Frank Armstrong held the position of Non-Executive Chairman at Summit Therapeutics at the time of this trade.
 Frank Armstrong
041,666122204
24-Oct-18Sell
Trade Notifier Information for Summit Therapeutics
Leopoldo Zambeletti held the position of Non-Executive Director at Summit Therapeutics at the time of this trade.
 Leopoldo Zambeletti
28.1GBX11,35815979
View more Summit Ther directors dealings >>


stew200
Posts: 11,152
Opinion:No Opinion
Price:31.00
Easyp
Sun 20:12
Surely summit is in the right place to capitalise
easyp
Posts: 1,565
Opinion:No Opinion
Price:31.00
FT Viewpoint
Sun 15:14
https://www.ft.com/content/4da1c6e4-603d-11e9-9300-0becfc937c37

Article in the FT by someone from the Welcome Trust

"The tragedy is not that investors have lost their money. Rather, it is the signal that there is no viable route to market for new antibiotics, however valuable they may be to society. Capital-starved smaller companies will fold. Innovation will die on the vine. Money already invested by governments and charities will be squandered."
Thoth2
Posts: 2,560
Opinion:No Opinion
Price:31.00
RE: New article
Thu 11:57
but can you trust the BOD ?
https://www.summitplc.com/app/uploads/2018/06/summitra2008.pdf
I was here a long time ago. and made a few bob. But where is the update on the Orient pharma collaboration, or the TB licence to Lilly. been waiting 10 years and no news. very selective with their news releases her. DYOR
Chrisatrdg
Posts: 1,489
Opinion:Strong Buy
Price:31.00
New article
16 Apr '19
easyp
Posts: 1,565
Opinion:No Opinion
Price:34.00
RE: RNS what it means.
15 Apr '19
Apparently so! Glad I purchased more last week!
View more share chat for Summit Ther (SUMM) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.